Pmv Pharmaceuticals Inc (PMVP)
$1.23
$-0.01
(-0.81%)
As on 28-Aug-2026 13:37EDT
Market cap
$71 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.6 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.4
-
Face value
--
-
Shares outstanding
53,458,058
6 Years Aggregate
CFO
$-235.97 Mln
EBITDA
$-293.01 Mln
Net Profit
$-277.45 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pmv Pharmaceuticals Inc (PMVP)
| -1.6 | 4.2 | 2.5 | -13.4 | -44.8 | -47.3 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pmv Pharmaceuticals Inc (PMVP)
| -17.2 | -51.0 | -64.4 | -62.3 | -62.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pmv Pharmaceuticals Inc (PMVP)
|
1.2 | 71.1 | 0.0 | -75.2 | -- | -85.4 | -- | 1.0 |
| 84.9 | 12,304.7 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.4 | |
| 72.3 | 10,682.6 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.2 | 13,400.0 | 2,435.9 | 860.6 | 31.0 | 43 | 17 | 7.3 | |
| 105.3 | 12,277.1 | 1,663.7 | 413.6 | 36.3 | 430 | 31.2 | 83.9 | |
| 350.5 | 10,258.4 | 440.5 | 241.5 | 33.4 | 18.7 | 42.2 | 7.3 | |
| 534.5 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 603.9 | 17,326.2 | 2,782.3 | 491.5 | 21.1 | 110.1 | 36.5 | 39.4 | |
| 348.4 | 10,496.2 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 142.6 | 9,985.8 | 282.0 | 82.9 | -28.6 | 11.4 | 147 | 11.6 |
Shareholding Pattern
View DetailsAbout Pmv Pharmaceuticals Inc (PMVP)
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural... corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey. Read more
-
Co-Founder, CEO, President & Director
Dr. David H. Mack Ph.D.
-
Co-Founder, CEO, President & Director
Dr. David H. Mack Ph.D.
-
Headquarters
Princeton, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Pmv Pharmaceuticals Inc (PMVP)
What is the current share price of Pmv Pharmaceuticals Inc (PMVP) Today?
The share price of Pmv Pharmaceuticals Inc (PMVP) is $1.23 (NASDAQ) as of 28-Aug-2026 13:37 EDT. Pmv Pharmaceuticals Inc (PMVP) has given a return of -44.82% in the last 3 years.
What is the current PB & PE ratio of Pmv Pharmaceuticals Inc (PMVP)?
Since, TTM earnings of Pmv Pharmaceuticals Inc (PMVP) is negative, P/E ratio is not available.
The P/B ratio of Pmv Pharmaceuticals Inc (PMVP) is 0.98 times as on 21-Aug-2026, a 82 discount to its peers’ median range of 5.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.86 |
0.64 |
2024 |
-1.33 |
0.44 |
2023 |
-2.31 |
0.71 |
2022 |
-5.42 |
1.62 |
2021 |
-18.09 |
3.39 |
What is the 52 Week High and Low of Pmv Pharmaceuticals Inc (PMVP)?
The 52-week high and low of Pmv Pharmaceuticals Inc (PMVP) are Rs 1.88 and Rs 1.02 as of 29-Aug-2026.
What is the market cap of Pmv Pharmaceuticals Inc (PMVP)?
Pmv Pharmaceuticals Inc (PMVP) has a market capitalisation of $ 71 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pmv Pharmaceuticals Inc (PMVP)?
Before investing in Pmv Pharmaceuticals Inc (PMVP), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.